Staphylococcal complement inhibitor modulates phagocyte responses by dimerization of convertases

The Journal of Immunology : Official Journal of the American Association of Immunologists
Ilse JongeriusSuzan H M Rooijakkers

Abstract

The human pathogen Staphylococcus aureus produces several complement-evasion molecules that enable the bacterium to withstand the host immune response. The human-specific staphylococcal complement inhibitor (SCIN) blocks the central C3 convertase enzymes that trigger critical complement functions, such as C3b deposition, phagocytosis, and C5a generation. SCIN effectively blocks the conversion of C3 by alternative pathway C3 convertases (C3bBb), but also induces dimerization of these enzymes. In this study, we show that formation of dimeric convertases by SCIN is important for S. aureus immune evasion because it modulates complement recognition by phagocytic receptors. Dimeric, but not monomeric, SCIN convertases showed an impaired binding to complement receptor 1 and the complement receptor of the Ig superfamily. The dimerization site of SCIN is essential for its strong antiphagocytic properties. These studies provide critical insights into the unique immune-evasion strategies used by S. aureus.

References

Oct 31, 1997·Inflammation·K E VeldkampJ A Van Strijp
May 5, 1998·Clinical and Experimental Immunology·M NickellsJ P Atkinson
Aug 26, 1998·The New England Journal of Medicine·F D Lowy
Apr 5, 2001·The New England Journal of Medicine·M J Walport
Apr 12, 2001·The New England Journal of Medicine·M J Walport
Jun 21, 2001·Immunological Reviews·Y XuJ E Volanakis
Jun 21, 2001·Immunological Reviews·M D Kirkitadze, P N Barlow
Nov 21, 2002·Biochemical Society Transactions·M K Pangburn, N Rawal
Jul 25, 2003·The Journal of Biological Chemistry·Nenoo Rawal, Michael K Pangburn
Jun 18, 2004·Immunological Reviews·Teizo FujitaYuichi Endo
Oct 13, 2004·Molecular Immunology·Philippe Gasque
Feb 25, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ries LangleyJohn D Fraser
Mar 29, 2005·Microbes and Infection·S H M RooijakkersJ A G van Strijp
Aug 9, 2005·Nature Immunology·Suzan H M RooijakkersJos A G van Strijp
Oct 26, 2005·Trends in Microbiology·Suzan H M RooijakkersJos A G van Strijp
Dec 13, 2005·Clinical Immunology : the Official Journal of the Clinical Immunology Society·David D Kim, Wen-Chao Song
Mar 15, 2006·Cell·Karim Y HelmyMenno van Lookeren Campagne
Oct 20, 2006·Nature·Christian WiesmannMenno van Lookeren Campagne
Sep 26, 2007·The Journal of Experimental Medicine·Ilse JongeriusSuzan H M Rooijakkers
Nov 20, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Daniel RicklinJohn D Lambris
Jul 25, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Daniel RicklinJohn D Lambris

❮ Previous
Next ❯

Citations

Dec 13, 2012·The Journal of Biological Chemistry·Brandon L GarciaBrian V Geisbrecht
Jul 10, 2013·Annual Review of Microbiology·András N SpaanJos A G van Strijp
Feb 13, 2016·Frontiers in Microbiology·Ana do ValeSandra Sousa
Jan 25, 2013·Clinical & Developmental Immunology·Gwendolyn CazanderPeter H Nibbering
Jun 16, 2015·Frontiers in Immunology·Nicolas S MerleLubka T Roumenina
Mar 14, 2018·Microorganisms·Pietro SpezialeGiampiero Pietrocola
Mar 17, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Brandon L GarciaBrian V Geisbrecht
May 15, 2010·Nature Reviews. Microbiology·Davide SerrutoJos A G van Strijp
Oct 29, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A RojoA España
Mar 24, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Chunfang GuYi Xu
Oct 27, 2016·Immunological Reviews·Daniel RicklinJohn D Lambris
Feb 16, 2017·Frontiers in Microbiology·Kaila M BennettRonald D Gorham
Nov 30, 2018·Medical Microbiology and Immunology·Vigyasa Singh, Ujjal Jyoti Phukan
Mar 6, 2021·Scientific Reports·Andi R SultanWillem J B van Wamel

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

The Journal of Immunology : Official Journal of the American Association of Immunologists
Daniel RicklinJohn D Lambris
The Journal of Experimental Medicine
Ilse JongeriusSuzan H M Rooijakkers
The Journal of Immunology : Official Journal of the American Association of Immunologists
Suzan H M RooijakkersPiet Gros
© 2022 Meta ULC. All rights reserved